Company: GEHC
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001932393-25-000005
Chunk: 79

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 8
Chunk 79
---
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Part II. Financial InformationIndexItem 8. Financial Statements and Supplementary DataPageReport of Independent Registered Public Accounting Firm - Deloitte & Touche LLP (PCAOB ID No. 34)57Consolidated and Combined Statements of Income60Consolidated and Combined Statements of Comprehensive Income (Loss)61Consolidated Statements of Financial Position62Consolidated and Combined Statements of Changes in Equity63Consolidated and Combined Statements of Cash Flows64Notes to the Consolidated and Combined Financial Statements65Note 1.     Organization and Basis of Presentation65Note 2.     Summary of Significant Accounting Policies66Note 3.     Revenue Recognition75Note 4.     Segment and Geographical Information76Note 5.     Receivables79Note 6.     Financing Receivables80Note 7.     Leases80Note 8.     Acquisitions, Goodwill, and Other Intangible Assets81Note 9.     Borrowings83Note 10.   Postretirement Benefit Plans84Note 11.   Income Taxes90Note 12.   Accumulated Other Comprehensive (Income) Loss – Net93Note 13.   Financial Instruments and Fair Value Measurements94Note 14.   Commitments, Guarantees, Product Warranties, and Other Loss Contingencies98Note 15.   Restructuring Activities100Note 16.   Share-Based Compensation100Note 17.   Earnings Per Share102Note 18.   Supplemental Financial Information103Note 19.   Related Parties and Transition Services Agreement106Note 20.   Subsequent Events108

56

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of GE HealthCare Technologies, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated statements of financial position of GE HealthCare Technologies, Inc. (the "Company") as of December 31, 2024 and 2023, the related consolidated and combined statements of income, comprehensive income (loss), changes in equity, and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and